Figure 1.Schematic overview of the findings from the characterization of mesenchymal stem cells (MSCs) derived from hiPSCs in MDPL patients and healthy donors.
Figure 1 — When do the pathological signs become evident? Study of human mesenchymal stem cells in MDPL syndrome | Aging
